Author

Sheng Fong

National University of SingaporeORCID 0000-0002-5834-512XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 2 Approach:benchmark study· 1 Organism:C. elegans· 1 Research Focus:cancer & tumor microenvironment· 1 Assay:clinical cohort / trial· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Amaury Cazenave‐GassiotiD· 1 shared Barry B. HalliwelliD· 1 shared Diogo BarardoiD· 1 shared Emelyne TeoiD· 1 shared Fang JiiD· 1 shared Hyung-Seok KimiD· 1 shared Jan GruberiD· 1 shared Jean‐Paul KovalikiD· 1 shared

Activity by Year

2019-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Amaury Cazenave‐GassiotORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NeurosciencebioRxivPreprintSep 28, 2026

Improving DASH adherence after midlife promotes better late-life cognition and brain health: the SG70 Study

Kwun Kei Ng, Jun S. Lai, Fang Ji…·Juan Helen Zhou

This study shows that better adherence to the DASH diet in midlife and early elderhood improves late-life verbal memory and brain health through structural and neurovascular mechanisms.

DOI 10.64898/2026.09.23.753372

humanclinical cohort / trial

𝕏 PostBluesky

NeuroscienceeLifePeer-reviewedOct 14, 2019

Metabolic stress is a primary pathogenic event in transgenic Caenorhabditis elegans expressing neuronal human amyloid-β

Emelyne Teo, Sudharshan Ravi, Diogo Barardo…·Jan Gruber

This study identifies metabolic dysfunction, particularly in the TCA cycle, as an early and causative event in Alzheimer's disease using a transgenic C. elegans model.

72 citationstop 2%

C. elegansmetabolomics

𝕏 PostBluesky